{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:52:06Z","timestamp":1777870326038,"version":"3.51.4"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"DOI":"10.1007\/s40620-024-02068-6","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T12:01:57Z","timestamp":1728043317000},"page":"2243-2253","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Urine epidermal growth factor as a biomarker for kidney function recovery and prognosis in glomerulonephritis with severe kidney function impairment"],"prefix":"10.1093","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8566-0094","authenticated-orcid":false,"given":"Adriana","family":"Hern\u00e1ndez-Andrade","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9763-8209","authenticated-orcid":false,"given":"Alberto","family":"Nordmann-Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3406-5448","authenticated-orcid":false,"given":"Bernardo","family":"Ju\u00e1rez-Cuevas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9072-6957","authenticated-orcid":false,"given":"Maria Fernanda","family":"Zavala-Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristino","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4062-9412","authenticated-orcid":false,"given":"Juan M.","family":"Mej\u00eda-Vilet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,10,4]]},"reference":[{"issue":"10335","key":"2068_CR1","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/S0140-6736(22)00461-5","volume":"399","author":"S Sethi","year":"2022","unstructured":"Sethi S, De Vriese AS, Fervenza FC (2022) Acute glomerulonephritis. Lancet 399(10335):1646\u20131663. https:\/\/doi.org\/10.1016\/S0140-6736(22)00461-5","journal-title":"Lancet"},{"issue":"6","key":"2068_CR2","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/MCC.0000000000000675","volume":"25","author":"R Fenoglio","year":"2019","unstructured":"Fenoglio R, Sciascia S, Baldovino S, Roccatello D (2019) Acute kidney injury associated with glomerular diseases. Curr Opin Crit Care 25(6):573\u2013579. https:\/\/doi.org\/10.1097\/MCC.0000000000000675","journal-title":"Curr Opin Crit Care"},{"issue":"4S","key":"2068_CR3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","author":"BH Rovin","year":"2021","unstructured":"Rovin BH, Adler SG, Barratt J, Bridoux F, Burdge KA, Chan TM et al (2021) KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int 100(4S):S1-276. https:\/\/doi.org\/10.1016\/j.kint.2021.05.021","journal-title":"Kidney Int"},{"issue":"1","key":"2068_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12916-016-0673-8","volume":"14","author":"JA Singh","year":"2016","unstructured":"Singh JA, Hossain A, Kotb A, Wells G (2016) Risk of serious infections with immunosuppressive drugs and glucocorticoids for lupus nephritis: a systematic review and network meta-analysis. BMC Med 14(1):137. https:\/\/doi.org\/10.1186\/s12916-016-0673-8","journal-title":"BMC Med"},{"issue":"7","key":"2068_CR5","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1093\/rheumatology\/keab818","volume":"61","author":"F Sun","year":"2022","unstructured":"Sun F, Wang H, Zhang D, Han F, Ye S (2022) One-year renal outcome in lupus nephritis patients with acute kidney injury: a nomogram model. Rheumatology (Oxford) 61(7):2886\u20132893. https:\/\/doi.org\/10.1093\/rheumatology\/keab818","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"2068_CR6","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1007\/s00467-022-05775-z","volume":"38","author":"BR Stotter","year":"2023","unstructured":"Stotter BR, Cody E, Gu H, Daga A, Greenbaum LA, Duong MD et al (2023) Acute kidney injury requiring kidney replacement therapy in childhood lupus nephritis: a cohort study of the Pediatric Nephrology Research Consortium and Childhood Arthritis and Rheumatology Research Alliance. Pediatr Nephrol 38(5):1653\u20131665. https:\/\/doi.org\/10.1007\/s00467-022-05775-z","journal-title":"Pediatr Nephrol"},{"issue":"8","key":"2068_CR7","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1007\/s10067-023-06629-1","volume":"42","author":"SE M\u00e1rquez-Macedo","year":"2023","unstructured":"M\u00e1rquez-Macedo SE, Perez-Arias AA, Pena-Vizcarra \u00d3R, Zavala-Miranda MF, Ju\u00e1rez-Cuevas B, Navarro-Gerrard MA et al (2023) Predictors of treatment outcomes in lupus nephritis with severe acute kidney injury and requirement of dialytic support. Clin Rheumatol 42(8):2115\u20132123. https:\/\/doi.org\/10.1007\/s10067-023-06629-1","journal-title":"Clin Rheumatol"},{"issue":"7","key":"2068_CR8","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1681\/ASN.2007010066","volume":"18","author":"De Lind","year":"2007","unstructured":"Lind De, van Wijngaarden RAF, Hauer HA, Wolterbeek R, Jayne DRW, Gaskin G, Rasmussen N et al (2007) Chances of renal recovery for dialysis-dependent ANCA-associated glomerulonephritis. J Am Soc Nephrol 18(7):2189\u20132197. https:\/\/doi.org\/10.1681\/ASN.2007010066","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"2068_CR9","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1007\/s10067-016-3195-z","volume":"35","author":"BM C\u00f3rdova-S\u00e1nchez","year":"2016","unstructured":"C\u00f3rdova-S\u00e1nchez BM, Mej\u00eda-Vilet JM, Morales-Buenrostro LE, Loyola-Rodr\u00edguez G, Uribe-Uribe NO, Correa-Rotter R (2016) Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvement. Clin Rheumatol 35(7):1805\u20131816. https:\/\/doi.org\/10.1007\/s10067-016-3195-z","journal-title":"Clin Rheumatol"},{"issue":"1","key":"2068_CR10","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/ndt\/gfh563","volume":"20","author":"I Neumann","year":"2005","unstructured":"Neumann I, Kain R, Regele H, Soleiman A, Kandutsch S, Meisl FT (2005) Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis. Nephrol Dial Transplant 20(1):96\u2013104. https:\/\/doi.org\/10.1093\/ndt\/gfh563","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"2068_CR11","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1046\/j.1523-1755.1999.00758.x","volume":"56","author":"IM Bajema","year":"1999","unstructured":"Bajema IM, Hagen EC, Hermans J, No\u00ebl LH, Waldherr R, Ferrario F et al (1999) Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis. Kidney Int 56(5):1751\u20131758. https:\/\/doi.org\/10.1046\/j.1523-1755.1999.00758.x","journal-title":"Kidney Int"},{"issue":"10","key":"2068_CR12","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1681\/ASN.2010050477","volume":"21","author":"AE Berden","year":"2010","unstructured":"Berden AE, Ferrario F, Hagen EC, Jayne DR, Jennette JC, Joh K et al (2010) Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol 21(10):1628\u20131636. https:\/\/doi.org\/10.1681\/ASN.2010050477","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"2068_CR13","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1093\/ndt\/gfab250","volume":"37","author":"M Casal Moura","year":"2022","unstructured":"Casal Moura M, Fervenza FC, Specks U, Sethi S (2022) Kidney biopsy chronicity grading in antineutrophil cytoplasmic antibody-associated vasculitis. Nephrol Dial Transplant 37(9):1710\u20131721. https:\/\/doi.org\/10.1093\/ndt\/gfab250","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"2068_CR14","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.kint.2018.07.020","volume":"94","author":"SR Brix","year":"2018","unstructured":"Brix SR, Noriega M, Tennstedt P, Vettorazzi E, Busch M, Nitschke M et al (2018) Development and validation of a renal risk score in ANCA-associated glomerulonephritis. Kidney Int 94(6):1177\u20131188. https:\/\/doi.org\/10.1016\/j.kint.2018.07.020","journal-title":"Kidney Int"},{"key":"2068_CR15","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.0000000000000274","author":"S Bate","year":"2023","unstructured":"Bate S, McGovern D, Costigliolo F, Tan PG, Kratky V, Scott J et al (2023) The improved kidney risk score in ANCA-associated vasculitis for clinical practice and trials. J Am Soc Nephrol. https:\/\/doi.org\/10.1681\/ASN.0000000000000274","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"2068_CR16","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1159\/000524586","volume":"53","author":"C Cortvrindt","year":"2022","unstructured":"Cortvrindt C, Speeckaert R, Delanghe JR, Speeckaert MM (2022) Urinary epidermal growth factor: a promising, \u201cNext Generation\u201d biomarker in kidney Disease. Am J Nephrol 53(5):372\u2013387. https:\/\/doi.org\/10.1159\/000524586","journal-title":"Am J Nephrol"},{"issue":"316","key":"2068_CR17","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aac7071","volume":"7","author":"W Ju","year":"2015","unstructured":"Ju W, Nair V, Smith S, Zhu L, Shedden K, Song PXK et al (2015) Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker. Sci Transl Med 7(316):316ra193. https:\/\/doi.org\/10.1126\/scitranslmed.aac7071","journal-title":"Sci Transl Med"},{"issue":"1","key":"2068_CR18","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.kint.2019.01.035","volume":"96","author":"K Azukaitis","year":"2019","unstructured":"Azukaitis K, Ju W, Kirchner M, Nair V, Smith M, Fang Z et al (2019) Low levels of urinary epidermal growth factor predict chronic kidney disease progression in children. Kidney Int 96(1):214\u2013221. https:\/\/doi.org\/10.1016\/j.kint.2019.01.035","journal-title":"Kidney Int"},{"issue":"10","key":"2068_CR19","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1093\/ndt\/gfad050","volume":"38","author":"LR Harskamp","year":"2023","unstructured":"Harskamp LR, Perez-Gomez MV, Heida JE, Engels GE, van Goor H, van den Heuvel MC et al (2023) The association of urinary epidermal growth factors with ADPKD disease severity and progression. Nephrol Dial Transplant 38(10):2266\u20132275. https:\/\/doi.org\/10.1093\/ndt\/gfad050","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"2068_CR20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/ndt\/gfy314","volume":"35","author":"L Wu","year":"2018","unstructured":"Wu L, Li XQ, Chang DY, Zhang H, Li JJ, Wu SL et al (2018) Associations of urinary epidermal growth factor and monocyte chemotactic protein-1 with kidney involvement in patients with diabetic kidney disease. Nephrol Dial Transplant 35(2):291\u2013297. https:\/\/doi.org\/10.1093\/ndt\/gfy314","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"2068_CR21","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s00467-018-3988-1","volume":"33","author":"B Li","year":"2018","unstructured":"Li B, Zhang Y, Wang F, Nair V, Ding F, Xiao H et al (2018) Urinary epidermal growth factor as a prognostic marker for the progression of Alport syndrome in children. Pediatr Nephrol 33(10):1731\u20131739. https:\/\/doi.org\/10.1007\/s00467-018-3988-1","journal-title":"Pediatr Nephrol"},{"key":"2068_CR22","doi-asserted-by":"publisher","first-page":"1122972","DOI":"10.3389\/fimmu.2023.1122972","volume":"14","author":"V Satrapova","year":"2023","unstructured":"Satrapova V, Sparding N, Genovese F, Karsdal MA, Bartonova L, Frausova D et al (2023) Biomarkers of fibrosis, kidney tissue injury and inflammation may predict severity and outcome of renal ANCA \u2013 associated vasculitis. Front Immunol 14:1122972. https:\/\/doi.org\/10.3389\/fimmu.2023.1122972","journal-title":"Front Immunol"},{"issue":"3","key":"2068_CR23","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/sj.ki.5002621","volume":"73","author":"DD Torres","year":"2008","unstructured":"Torres DD, Rossini M, Manno C, Mattace-Raso F, D\u2019Altri C, Ranieri E et al (2008) The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy. Kidney Int 73(3):327\u2013333. https:\/\/doi.org\/10.1038\/sj.ki.5002621","journal-title":"Kidney Int"},{"issue":"2","key":"2068_CR24","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/art.41507","volume":"73","author":"JM Mejia-Vilet","year":"2021","unstructured":"Mejia-Vilet JM, Shapiro JP, Zhang XL, Cruz C, Zimmerman G, M\u00e9ndez-P\u00e9rez RA et al (2021) Association between urinary epidermal growth factor and renal prognosis in lupus nephritis. Arthritis Rheumatol 73(2):244\u2013254. https:\/\/doi.org\/10.1002\/art.41507","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"2068_CR25","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.147464","volume":"6","author":"S Menez","year":"2021","unstructured":"Menez S, Ju W, Menon R, Moledina DG, Philbrook HT, McArthur E et al (2021) Urinary EGF and MCP-1 and risk of CKD after cardiac surgery. JCI Insight 6(11):e147464. https:\/\/doi.org\/10.1172\/jci.insight.147464","journal-title":"JCI Insight"},{"issue":"6","key":"2068_CR26","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.kint.2023.08.007","volume":"104","author":"S Menez","year":"2023","unstructured":"Menez S, Wen Y, Xu L, Moledina DG, Thiessen-Philbrook H, Hu D et al (2023) The ASSESS-AKI Study found urinary epidermal growth factor is associated with reduced risk of major adverse kidney events. Kidney Int 104(6):1194\u20131205. https:\/\/doi.org\/10.1016\/j.kint.2023.08.007","journal-title":"Kidney Int"},{"key":"2068_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/kisup.2012.1","volume":"2","author":"Kidney Disease Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group","year":"2012","unstructured":"Kidney Disease Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group (2012) KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2:1\u2013138","journal-title":"Kidney Int Suppl"},{"issue":"4","key":"2068_CR28","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.kint.2017.11.023","volume":"93","author":"IM Bajema","year":"2018","unstructured":"Bajema IM, Wilhelmus S, Alpers CE, Bruijn JA, Colvin RB, Cook HT et al (2018) Revision of the International Society of Nephrology\/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney Int 93(4):789\u2013796. https:\/\/doi.org\/10.1016\/j.kint.2017.11.023","journal-title":"Kidney Int"},{"issue":"2","key":"2068_CR29","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1523-1755.2004.00443.x","volume":"65","author":"JJ Weening","year":"2004","unstructured":"Weening JJ, D\u2019agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB et al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 65(2):521\u2013530. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00443.x","journal-title":"Kidney Int"},{"key":"2068_CR30","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group","year":"2021","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group (2021) KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int 100:S1\u2013S276. https:\/\/doi.org\/10.1016\/j.kint.2021.05.021","journal-title":"Kidney Int"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-02068-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-024-02068-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-02068-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:53:29Z","timestamp":1777564409000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/37\/8\/2243\/8306307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,4]]},"references-count":30,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["2068"],"URL":"https:\/\/doi.org\/10.1007\/s40620-024-02068-6","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,4]]},"assertion":[{"value":"31 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Research and Ethics Board of Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n (NMM-3496).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The study complies with the guidelines for human studies.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Written informed consent was obtained from all participants.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}